Yan Xi
Impact in
-
- Flavonoids in Medical Research
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 3
- Natural product bioactivities and synthesis 2
- Retinoids in leukemia and cellular processes 2
-
- Autophagy in Disease and Therapy 4
- Co-authors
- Kai Zhang (1 shared paper)Arun Dharmarajan (1 shared paper)Ming Gao (1 shared paper)Chenyang Xu (1 shared paper)Markus D. Lacher (1 shared paper)Li‐Jiang Xuan (1 shared paper)Richard Jäger (1 shared paper)Susanne Saurer (1 shared paper)
- Journals
- Autophagy (2 papers)Nanoscale (2 papers)iScience (1 paper)Oncology Reports (1 paper)Technology in Cancer Research & Treatment (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yan Xi
20 papers receiving 320 citations
Peers
Comparison fields: 5 of 81
- Pharmacology 62
- Cancer Research 52
- Molecular Biology 188
- Applied Microbiology and Biotechnology 5
- Molecular Medicine 10
Countries citing papers authored by Yan Xi
This map shows the geographic impact of Yan Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Xi more than expected).
Fields of papers citing papers by Yan Xi
This network shows the impact of papers produced by Yan Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Xi. The network helps show where Yan Xi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Xi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 56 | |
| 2 | 2015 | 44 | |
| 3 | 2003 | 44 | |
| 4 | 2014 | 29 | |
| 5 | 2016 | 24 | |
| 6 | 2021 | 21 | |
| 7 | 2019 | 18 | |
| 8 | 2023 | 17 | |
| 9 | 2024 | 16 | |
| 10 | 2019 | 11 | |
| 11 | 2021 | 10 | |
| 12 | 2014 | 10 | |
| 13 | 2012 | 8 | |
| 14 | 2024 | 5 | |
| 15 | The establishment and characterization of adriamycin-resistant cell lines derived from Saos-2. | 2010 | 4 |
| 16 | 2024 | 4 | |
| 17 | 2014 | 2 | |
| 18 | The mechanism of apoptosis of TE-13 cells induced by ethanol extract of Forsythia suspensa root in vitro | 2013 | 1 |
| 19 | [Amplification efficency and optimization of culture conditions of γδ T cells in peripheral blood by different phosphate compounds]. | 2014 | 1 |
| 20 | [Construction of a mouse model of type 2 diabetes induced by high fat diet alone and evaluation of pathological changes]. | 2024 | 1 |
About Yan Xi
Yan Xi is a scholar working on Molecular Biology, Epidemiology, Health, Toxicology and Mutagenesis, Genetics and Immunology, having authored 24 papers that have together received 326 indexed citations. Recurring topics across this work include Air Quality and Health Impacts (4 papers), Climate Change and Health Impacts (4 papers), Autophagy in Disease and Therapy (4 papers), Epigenetics and DNA Methylation (3 papers), Natural product bioactivities and synthesis (2 papers), Birth, Development, and Health (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Phytochemistry and Biological Activities (2 papers). The work is most often cited by research in Pharmacology (62 citations), Cancer Research (52 citations), Molecular Biology (188 citations), Applied Microbiology and Biotechnology (5 citations) and Molecular Medicine (10 citations). Yan Xi has collaborated with scholars based in China, United States and France. Frequent co-authors include Kai Zhang, Kai Zhang, Arun Dharmarajan, Ming Gao, Chenyang Xu, Markus D. Lacher, Li‐Jiang Xuan, Richard Jäger, Susanne Saurer and Ricky R. Lareu. Their work appears in journals such as Autophagy, Nanoscale, iScience, Oncology Reports and Technology in Cancer Research & Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.